A Phase 1, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Antitumor Activities of the anti-PD-1 Monoclonal Antibody BGB-A317 in Subjects with Advanced Tumors

  • Markman, Ben (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

SERP Reference Number: HREC/15/MH/77.
SSA Reference Number: SSA/15/MonH/68.
Monash Health HREC Ref: 15295X

Effective start/end date20/12/1819/12/23